CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
Sheng-jun Wang, Xue-wu Liu Department of Neurology, Qilu Hospital, Shandong University, Ji’nan, People’s Republic of ChinaCorrespondence: Sheng-jun Wang; Xue-wu LiuDepartment of Neurology, Qilu Hospital, Shandong University, 107# Wen Hua Xi Road, Ji’nan 250012, People&a...
Enregistré dans:
Auteurs principaux: | Wang S, Liu X |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aec84005bdda4c29aa41946044fb56fb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
par: Wei M, et autres
Publié: (2020) -
CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
par: Lin Y, et autres
Publié: (2019) -
Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study
par: Qiao S, et autres
Publié: (2021) -
Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment
par: Huang C, et autres
Publié: (2015) -
Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review
par: Guo YH, et autres
Publié: (2014)